Hematological malignancies are highly heterogeneous. A correct diagnosis needs integration of several tools and platforms so that hematologists can select the best strategy for treatment and follow-up. The test system encompasses morphology, flow cytometry, and molecular tests for peripheral blood, bone marrow, and body fluid. These highly complex tests are time-consuming, labor-intensive, and far from standardization. To deal these problems, we will introduce a slide scanning system , an artificial intelligence (AI) system for marrow cell morphology, the eight-color dried antibodies in flow cytometry, and a panel of the next-generation sequencing method.
Four advantages of Integrative Platform for Hematological Examination:
1.We will introduce a slide scanning system through which the clinicians can immediately access patients' bone marrow morphology at the remote sites.
2.We also have developed an artificial intelligence (AI) system, which can more efficiently and precisely identify the marrow cells and store the image files for training purposes.
3.We are the first to apply the eight-color dried antibodies in flow cytometry.
4.We have developed a panel of the next-generation sequencing method to efficiently analyze the mutation status of 30 genes in myeloid malignancies.
Agents/distributors, and healthcare providers are welcome to collaborate.